Case report of a lupus patient with a severe flare and miliary tuberculosis: need for proper guidelines for management

Abstract Systemic lupus erythematosus (SLE) is an autoimmune disease that is frequently treated with high doses of corticosteroids and other immunosuppressive drugs. Thus patients with SLE are at increased risk for infections with several pathogens including Mycobacterium tuberculosis. There are no...

Full description

Saved in:
Bibliographic Details
Published in:Oxford Medical Case Reports 2017-07, Vol.2017 (7), p.omx030
Main Authors: Hashmat, Masooma, Rana, Ramsa Suhail, Mahmud, Tafazzul-e-Haque, Rasheed, Aflak, Rehman, Ata Ur, Pirzada, Syed Ali Rukh, Asghar, Muhammad Ammad, Asif, Sadia, Ali, Amjad
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Systemic lupus erythematosus (SLE) is an autoimmune disease that is frequently treated with high doses of corticosteroids and other immunosuppressive drugs. Thus patients with SLE are at increased risk for infections with several pathogens including Mycobacterium tuberculosis. There are no established guidelines available for treatment of tuberculosis in SLE patients with high disease activity due to lack of relevant studies and management based more on physician expertise. We report a case of a young SLE patient with high disease activity index (SLEDAI19) as evidenced by the presence of a vasculitic rash, non-healing ulcer on forearm and proteinuria of >1 g/d along with miliary tuberculosis. She was treated with intravenous methylprednisolone pulse up to 3 g and antituberculous therapy, but the result was a fatal outcome. This case report emphasizes the need for formal guidelines for co-management of active tuberculosis and SLE with high disease activity.
ISSN:2053-8855
2053-8855
DOI:10.1093/omcr/omx030